skip to main content

Parkinson’s medicines timing — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCNS TherapeuticsParkinson’s medicines timingGPhC CRA

Care-home staff ask to move co-careldopa doses to standard medicines rounds rather than the patient’s usual times. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Keep co-careldopa at the patient’s usual times

This scenario assesses Parkinson’s medicines timing in a UK pharmacy practice context. Parkinson’s medicines are time-critical and delays can cause marked deterioration. The best answer is Keep co-careldopa at the patient’s usual times because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF; NICE CKS